We announced our quarter 1 2024 results on Wednesday, May 1st. By bringing outstanding people together in an inclusive environment to do work that matters, we can impact the world’s health.

We are a focused biopharma company with strong momentum and big ambitions, to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive.

GSK has been active, with the World Health Organization (WHO), in the Global Alliance to Eliminate Lymphatic Filariasis (GAELF). Around 120 million people globally are believed to be infected with lymphatic filariasis. [122]

Request a non-vaccine prescription medicine refill. Find more information a patient assistance program to help eligible patients receive certain GSK prescription medicines and vaccines at no cost.

At GSK, we unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive.

Learn more about our product portfolio and how we’re prioritizing specialty medicines and vaccines to get ahead of disease together. Below you can find the full A-Z list of our products available in the United States. Unfortunately, we cannot provide comprehensive information about our products here, in compliance with regulations.

At GSK, our portfolio and pipeline is focused in developing medicines and vaccines in four core therapeutic areas, which are the areas of human health we focus on to prevent and treat disease: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases.

GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. In Pakistan, the Company has been providing trusted quality medicines and vaccines to more than 200 million patients for over seven decades.

Feb 22, 2022 · GlaxoSmithKline plc (GSK) today announced that the new company, to result from the proposed demerger of Consumer Healthcare from GSK in mid-2022, will be called Haleon.

AccessGSK ... Sign In